Newman Dignan & Sheerar Inc. Buys New Stake in JPMorgan International Research Enhanced Equity ETF $JIRE

Newman Dignan & Sheerar Inc. acquired a new stake in JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 72,171 shares of the company’s stock, valued at approximately $5,930,000. JPMorgan International Research Enhanced Equity ETF accounts for 1.1% of Newman Dignan & Sheerar Inc.’s holdings, making the stock its 22nd biggest holding. Newman Dignan & Sheerar Inc. owned approximately 0.05% of JPMorgan International Research Enhanced Equity ETF at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the business. Carnegie Investment Counsel acquired a new stake in JPMorgan International Research Enhanced Equity ETF in the 3rd quarter valued at about $657,000. Prime Capital Investment Advisors LLC purchased a new position in shares of JPMorgan International Research Enhanced Equity ETF in the 3rd quarter valued at $408,000. Smithbridge Asset Management Inc. DE purchased a new position in shares of JPMorgan International Research Enhanced Equity ETF in the 3rd quarter valued at $12,602,000. Fairvoy Private Wealth LLC raised its stake in JPMorgan International Research Enhanced Equity ETF by 9.0% during the 3rd quarter. Fairvoy Private Wealth LLC now owns 8,043 shares of the company’s stock worth $661,000 after acquiring an additional 665 shares in the last quarter. Finally, First Bank & Trust raised its stake in JPMorgan International Research Enhanced Equity ETF by 20.5% during the 3rd quarter. First Bank & Trust now owns 25,451 shares of the company’s stock worth $2,091,000 after acquiring an additional 4,326 shares in the last quarter.

JPMorgan International Research Enhanced Equity ETF Price Performance

Shares of JIRE opened at $82.03 on Wednesday. JPMorgan International Research Enhanced Equity ETF has a 1-year low of $71.85 and a 1-year high of $86.07. The stock has a market cap of $11.01 billion, a PE ratio of 16.04 and a beta of 0.78. The firm has a fifty day moving average price of $83.53 and a 200 day moving average price of $82.01.

JPMorgan International Research Enhanced Equity ETF Profile

(Free Report)

The JPMorgan International Research Enhanced Equity ETF (JIRE) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed ETF that provides exposure to stocks of any market capitalization from developed markets, excluding North America. JIRE was launched on Jun 10, 2022 and is managed by JPMorgan Chase.

Further Reading

Want to see what other hedge funds are holding JIRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report).

Institutional Ownership by Quarter for JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE)

Receive News & Ratings for JPMorgan International Research Enhanced Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan International Research Enhanced Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.